Context: Fibroblast growth factor 23 (FGF23) plays an important role in phosphate homeostasis, but its regulation is inadequately characterized.
Main Outcome Measures: Intact and C-terminal FGF23 concentrations and iron status at 1 year of age.
Results: Intact FGF23 was greater in girls than in boys [median, 44.4 pg/mL; interquartile range (IQR), 36.8 to 51.9; median, 40.9 pg/mL; IQR, 34.5 to 49.0, respectively; P , 0.001]. C-terminal FGF23 was similar in boys and girls (median, 2.8 pmol/L; IQR, 2.1 to 3.7; median, 2.9 pmol/L; IQR, 2.2 to 3.7, respectively; P = 0.393). The iron concentration was positively associated with intact FGF23 and was the strongest modifier of intact FGF23 (regression coefficient, 0.498; 95% confidence interval, 0.333 to 0.663; P , 0.001) with ferritin, season, ionized calcium, 25OHD, and sex as other covariates. The association between iron and C-terminal FGF23 was inversely related (regression coefficient, 20.072; 95% confidence interval, 20.092 to 20.051; P , 0.001). Regulation of FGF23 is complex and not yet fully understood. In addition to regulation by phosphate, parathyroid hormone (PTH), and 1,25-dihydroxyvitamin D, other factors are involved (4) . We previously demonstrated that intact FGF23 concentrations in early infancy (age 3 months) differ between the sexes, with girls having substantially greater concentrations than those in boys (5) . Differences between the sexes in C-terminal FGF23 concentrations have been demonstrated in older children, and age-related variations have also been suggested (6) (7) (8) .
Conclusions
The effects of iron deficiency on FGF23 concentrations were first discovered when studying autosomal dominant hypophosphatemic rickets (ADHR), caused by gain of function mutations in the FGF23 gene (9, 10) . These mutations prevent cleavage of FGF23 and lead to increased circulating levels of intact FGF23, hyperphosphaturia, and hypophosphatemia (11) . In adults with ADHR and in knock-in ADHR mice, iron deficiency or low iron concentrations correlate inversely with both intact and C-terminal FGF23 (12, 13) . In healthy adults, iron deficiency promotes increased expression and cleavage of FGF23, resulting in increased C-terminal FGF23 concentrations but normal intact FGF23 concentrations and normal phosphate levels (11, 14) . In wild-type mice, iron deficiency results in elevated intact FGF23 in pups but not in adult mice (13) , suggesting that FGF23 cleavage mechanisms could be immature and change with age.
The physiological regulators of FGF23 metabolism remain inadequately characterized. Our study aimed to further study these regulators and, especially, the role of sex and iron status on FGF23 concentrations in a large cohort of 1-year-old healthy infants.
Subjects and Methods

Participants
The present study was a part of the VIDI (vitamin D intervention in infants) study, a controlled, double-blinded trial conducted at the Kätilöopisto Maternity Hospital in Helsinki, Finland. The study was conducted in accordance with the Declaration of Helsinki. The research ethics committee of the Hospital District of Helsinki and Uusimaa approved the study (approval no. 107/13/03/03/2012). The trial protocol is registered in ClinicalTrials.gov (NCT01723852). All the parents provided written informed consent at recruitment.
From January 2013 to June 2016, 987 healthy, term infants with weight appropriate for gestational age were randomized to receive daily vitamin D 3 supplementation of either 10 mg (400 IU) or 30 mg (1200 IU) from 2 weeks to 2 years of age. We have previously described the study protocol and detailed the inclusion and exclusion criteria (15) . The data provided in the present report represents the participants in both VIDI intervention groups. To examine sex differences in FGF23 concentrations, we included 721 children (51% girls) with complete data available on the background factors and concentrations of FGF23, 25-hydroxyvitamin D (25OHD), ionized calcium, phosphate, and PTH at 1 year of age. When analyzing the effect of iron status on FGF23 concentrations, the data analysis included data from 650 children (51% girls). Maternal and infant data were collected from the medical records at recruitment. Detailed descriptions of baseline data and maternal and umbilical cord blood 25OHD levels, including analyses by season (winter, spring, summer, autumn), have previously been reported (16) . Anthropometric measurements and venous blood samples were obtained at the 12-month follow-up visits. Growth was evaluated using Finnish pediatric growth references (17) . The plasma and serum aliquots were stored at 280°C until analysis.
Biochemical variables
Analysis of FGF23, 25OHD, and PTH concentrations were performed at the Pediatric Research Centre, University of Helsinki. Concentrations of intact and C-terminal FGF23 were determined from plasma samples using commercially available enzyme-linked immunosorbent assay kits by Kainos Laboratories (Tokyo, Japan) for intact FGF23 and Biomedica Medizinprodukte GmbH & Co KG (Vienna, Austria) for C-terminal FGF23, according to the manufacturers' instructions. The assay used for determining C-terminal FGF23 concentrations measures both C-terminal and intact FGF23 fragments. Both assays have been shown to have good sensitivity and to also reliably measure intact FGF23 at lower ferritin levels (18, 19) . Duplicate analysis of randomly selected subgroups of 38 intact and 36 Cterminal FGF23 samples showed a mean coefficient of variation of 2% and 7%, respectively. The detection range was 0 to 800 pg/mL for intact and 0 to 20 pmol/L for C-terminal FGF23.
Serum concentrations of 25OHD and PTH were analyzed using an IDS-iSYS fully automated immunoassay system (Immunodiagnostic Systems, Ltd., Bolton, UK) with chemiluminescence detection. All samples were analyzed in the same batch. The intra-assay variation for serum 25OHD was 7% and for PTH was ,6%. The quality and accuracy of the serum 25OHD analyses were validated by participation in the vitamin D External Quality Assessment Scheme (Charing Cross Hospital, London, UK). The method showed a 6% positive bias compared with the National Institute of Standards and Technology standards in international comparisons. PTH concentrations that were undetectably low (n = 19) were coded as 4.4 pg/mL (lower detection limit, 4.5 pg/mL).
Laboratory analyses of ionized calcium, phosphate, alkaline phosphatase, creatinine, hemoglobin, mean corpuscular volume, iron, ferritin, transferrin, and transferrin-saturation were performed at the Central Laboratory of Helsinki University Hospital using standard, accredited photometric, impedance, and flow-cytometric methods. Central Laboratory of Helsinki University Hospital is an accredited laboratory adhering to international (T055) SFS-EN ISO 15189 and SFS-EN ISO/IEC 17025 standards.
Statistical analysis
The results for the groups are presented as the median and interquartile range (IQR). An independent samples t test with normally distributed variables, the Mann-Whitney U test for variables lacking normal distribution after logarithmic transformation, and the Pearson x 2 test with categorical variables enabled comparisons between the sexes. Factors with an effect on FGF23 concentration were examined in linear regression models. The final models included independent modifying variables with P , 0.05. When analyzing the effect of iron concentration (presented in quartiles), or season, on the other continuous variables, analysis on variance was performed, and the Tukey test served as a post hoc test, with Bonferroni correction for multiple comparisons. P , 0.05 was considered statistically significant. For data analyses, we used IBM SPSS Statistics 22 (IBM, Armonk, NY).
Results
Cohort characteristics
The study cohort comprised 721 children aged 1 year (range, 0.98 to 1.01 years; 51% girls) who participated in the VIDI study. In accordance with the inclusion criteria, children had been born at term, and the birth sizes were appropriate for gestational age (Table 1. ). At birth and at the 1-year follow-up visit, the boys weighed more (P ,0.001) and were longer (P ,0.001) than were the girls ( Table 1. ). Owing to the original recruitment schedule, sample collection occurred most often during spring (44%).
Biochemical findings
The median intact FGF23 concentration was 40.9 pg/mL (IQR, 34.5 to 49.0) in the boys and 44.4 pg/mL (IQR, 36.8 to 51.9) in the girls (Fig. 1) . The concentration was 8% greater in the girls (P , 0.001; Table 1 ). The median C-terminal FGF23 concentrations were similar in the boys and girls (median, 2.8 pmol/L; IQR, 2.1 to 3.7; and median, 2.9 pmol; IQR, 2.2 to 3.7, respectively; P = 0.393) (Fig. 1) . These findings persisted after adjustment for weight, length Z-score, weight/length ratio, hemoglobin, and ferritin.
Most children were vitamin D sufficient. The median serum 25OHD concentration was 95 nmol/L (IQR, 78 to 118) in the boys and 99 nmol/L (IQR, 79 to 118) in the girls (P = 0.356). Moreover, the median PTH concentration was normal in the boys and girls (23 and 24 pg/mL respectively; normal range, 15 to 65 ng/L). The ionized calcium concentration was greater in the girls than in the boys (1.34 vs 1.33 mmol/L; P = 0.002; normal range, 1.16-1.39 mmol/L), and the serum alkaline phosphatase concentration was greater in the boys than in the girls (286 vs 268 U/L; P = 0.039; normal range, 115 to 460 U/L). The phosphate concentrations were within the normal age-appropriate range (1.3 to 2.2 mmol/L) for all subjects and were similar in the boys and girls. The median hemoglobin concentration was greater in the boys than in the girls (120 vs 118 g/L; range, 81 to 142; P = 0.007). Altogether, 92 children (15%) had hemoglobin less than the age-specific reference (range, 111 to 142 g/L), and 61% of these were girls. The iron concentration was less than the reference value (#7 mmol/L) in 151 children (23%), without any sex difference (P = 0.826). The range for the iron concentration was 2 to 31 mmol/L. Ferritin was lower in the boys than in the girls (18 vs 26 mg/L; range, 3 to 254 mg/L; P , 0.001). Twelve children (2%) had a ferritin concentration less than the lower reference value (6 mg/L). Only 4 boys and 1 girl had mild iron-deficiency anemia defined as concurrently low hemoglobin and ferritin concentrations.
Key modifiers of FGF23
The key modifiers of intact FGF23 at 1 year were iron, season, sex, 25OHD, ionized calcium, and ferritin (Table 2) . After stratifying the analyses by sex, iron and season remained relevant factors in both (Table 3) . Higher iron concentration and winter, compared with the other seasons, associated with higher intact FGF23. In the whole group and separately in girls, 25OHD and ionized calcium concentrations were associated positively, and ferritin inversely, with intact FGF23. Phosphate was not a substantial modifier of intact FGF23.
Regarding C-terminal FGF23, the iron concentration and weight at 1 year were modifying factors. The greater the iron concentration, the lower the C-terminal FGF23 (Table 2) .
When the participants were divided into quartiles according to the iron concentration, both intact and Cterminal FGF23 differed among the quartiles (Table 4 ; Fig. 1 ). In the highest iron quartile, intact FGF23 was greater than that in the other quartiles. In addition, in the lowest iron quartile, C-terminal FGF23 was greater than that in other quartiles. The phosphate concentration was associated positively with the iron concentration. In contrast, 25OHD and PTH did not differ among the iron quartiles. Bonferroni correction did not affect the results. To summarize, iron was an independent modifier of both intact and C-terminal FGF23 concentrations and correlated with the phosphate concentration. A high iron concentration was associated with high serum intact FGF23, low C-terminal FGF23, and high phosphate concentrations.
Discussion
To the best of our knowledge, this is the first study to evaluate the FGF23 concentration and its regulators, especially the role of sex and iron status, in this interplay in healthy 1-year-old children. The key findings of the present study were that a substantial difference was found in intact FGF23 concentrations between boys and girls at 1 year of age. This difference was smaller than that in our previous study of 3-month-old infants but still clearly evident. In addition, iron had a substantial effect on the FGF23 concentrations at 1 year of age. The iron concentration was the most important modifying factor for intact FGF23 concentration, in addition to sex, season, 25OHD, ionized calcium, and ferritin. A higher iron concentration was associated with higher intact FGF23 levels. Season and ionized calcium levels were associated with the FGF23 concentrations in girls but not in boys. Serum phosphate was not a relevant modifier of FGF23 status.
Recently, some studies of different populations, mostly of school-age children or adults, have highlighted the regulatory role of iron in FGF23 metabolism (8, 11, 12, 14) . In small children, the regulatory mechanisms could be different, and regulating factors could be present that are no longer seen in adulthood. For example, among healthy 3-month-old infants, we previously observed that girls presented with almost 50% greater intact FGF23 concentrations than those in boys (5). This was a finding that was also confirmed in the present large cohort, in which the difference between boys and girls at 1 year of age was less marked, 8%, but still similar in direction. We have hypothesized that mini-puberty, the activation of the hypothalamic-pituitary-gonadal axis (20) , and, especially, the high testosterone concentrations in boys during infancy could regulate FGF23 metabolism. The most substantial endocrine manifestations of minipuberty occur during the first 6 months of life. Thus, it is unlikely that mini-puberty alone could explain the Analysis conducted using linear regression model with forward method, including ionized calcium, 25OHD, ferritin, and season as independent confounders.
Abbreviations: b, standardized regression coefficient; B, regression coefficient; CI, confidence interval. a All factors with P , 0.05 reported.
persistent differences in the FGF23 concentrations between girls and boys. Growth velocity is lower in girls than in boys, especially during the first 6 months of life (21) . Growth velocity decreases from birth and plateaus before the age of 1 year. Our observation of sex-related differences in intact FGF23 concentrations could promote phosphate sparing in boys compared with girls, and this could be a physiological adjustment for the greater phosphate need in boys during the rapid growth period. Fetal phosphate levels are relatively high and decrease within a few days after birth, concurrently with cessation of placental phosphate influx and resolution of transient hypoparathyroidism. Rodent models and infant data have shown that the intact FGF23 concentration increases rapidly after birth (22, 23) ; thus, FGF23 might have an important role in regulating the phosphate balance in early infancy. Because iron status and FGF23 are associated already in cord blood (24) , iron is likely to have a regulatory role at that point. The physiological regulators of phosphate homeostasis during early childhood remain inadequately understood and should be explored in longitudinal studies. The results of the present study have shown an association between iron and intact and C-terminal FGF23. This observation is in line with those from other studies of older children and adults but has not previously been evaluated in young children. In an iron-deficient population, a low iron concentration leads to stimulation of FGF23 expression and, further, to increased cleavage of intact FGF23, resulting in increased Cterminal FGF23 (14) . Unlike previous studies, we also observed an association between iron and intact FGF23 concentrations, with lower iron concentrations associated with lower intact FGF23 levels. Our cohort was large, enabling us to detect associations that might not have been evident in smaller studies. Furthermore, our cohort was mainly iron sufficient. We observed that in higher iron quartiles, the ratio between intact and Cterminal FGF23 increased; thus, the relative rate of cleavage was lower. It is possible that the importance of iron as an FGF23 regulator varies depending on the subject's state of iron sufficiency.
Age-dependent regulation patterns could also play a role in our cohort and be specific to this age group. In ADHR, the incomplete penetrance of the disease and the observation that disease onset can coincide with iron deficiency, has led to several studies examining the role of iron in FGF23 metabolism. In a rodent model, iron deficiency resulted in increased Fgf23 expression in osteocytes (10) . In iron-deficient mice with the ADHR mutation in Fgf23, intact and C-terminal FGF23 were increased. In contrast, iron-deficient wild-type mice presented merely with increased C-terminal FGF23. However, iron deficiency led to increased intact and Cterminal FGF23 in both wild-type and ADHR mice during the neonatal period (13) , with an inverse association between ferritin and C-terminal FGF23 seen in cord blood (24) . Thus, the regulatory role of iron in FGF23 metabolism and the regulation of FGF23 cleavage might change with age.
The concentration of the iron-binding protein ferritin reflects the iron stores of the body (25) . The total amount of body iron and its distribution varies during infancy (26) . Compared with the iron concentration, the ferritin concentration changes more slowly. Our finding of a lower ferritin concentration in boys could result from their greater demand for iron during the period of rapid growth. The prevalence of iron-deficiency anemia was low in our cohort. Also, the children who were small for gestational age or preterm and, thus, at an elevated risk of iron deficiency, were excluded from the present cohort.
Our study was limited to a cross-sectional evaluation of FGF23 and its regulators. Examination of longitudinal changes in FGF23 concentrations was not possible in the present cohort owing to the limited blood volume available. Our previous cohort of 3-month-old infants was recruited at the same maternity hospital in Helsinki and the inclusion criteria were identical for both studies. Thus, our previous and present results are likely to be comparable and allow for some conclusions regarding the age-related changes in FGF23 and its regulators during infancy.
In conclusion, at 1 year of age, girls presented with significantly greater intact FGF23 concentrations than did boys. Compared with 3-month-old children, the difference between the sexes was considerably smaller. The iron concentration had an effect on both intact and C-terminal FGF23 concentrations. Iron was the strongest modifier of intact FGF23 concentration. A high iron concentration was associated with high serum intact FGF23 and low C-terminal FGF23. Furthermore, in addition to the iron concentration, sex-related factors participate in the regulation of FGF23 metabolism. These findings indicate that differences between boys and girls in mineral homeostasis are evident at the age of 1 year. Further studies are warranted to understand the sexdependent differences we found in FGF23 regulation. Whether optimization of iron status in early childhood has wider bone health implications also remains to be explored in future studies.
